A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial. (Q50976609)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial. (English)

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

phase II clinical trial

0 references

Cytomegalovirus

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Michael Boeckh

1 reference

Europe PubMed Central

26 March 2018

author name string

Mohamed A Kharfan-Dabaja

1

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

Marissa B Wilck

3

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

Amelia A Langston

4

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

Alice H Chu

5

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

Mary K Wloch

6

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

Don F Guterwill

7

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

Larry R Smith

8

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

Alain P Rolland

9

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

Richard T Kenney

10

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

publication date

10 January 2012

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

Lancet Infectious Diseases

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

12

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

290-299

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

4

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Preemptive versus prophylactic protocol to prevent cytomegalovirus infection after renal transplantation: a meta-analysis and systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

How we treat cytomegalovirus in hematopoietic cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

An international comparison of current strategies to prevent herpesvirus and fungal infections in hematopoietic cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-amino ester polymers facilitate in vivo DNA transfection and adjuvant plasmid DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Physical characterization and in vivo evaluation of poloxamer-based DNA vaccine formulations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A DNA-based vaccine for the prevention of human cytomegalovirus-associated diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple approximation for calculating sample sizes for comparing independent proportions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cox's Regression Model for Counting Processes: A Large Sample Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970344-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(11)70344-9

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22237175

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50976609&oldid=1417868165"